| |
 |
|
Class Information
Number: 540/113
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium or tellurium) or nitrogen as the only ring hetero atoms > Cyclopentanohydrophenanthrene ring system containing > Nitrogen containing hetero ring attached indirectly to the cyclopentanohydrophenanthrene ring system by nonionic bonding > Chalcogen in chain between the hetero ring and the cyclopentanohydrophenanthrene ring system
Description: Compounds in which chalogen (i.e., oxygen, sulfur, selenium or tellurium) is in the chain between the hetero ring and the cyclopentanohydrophenanthrene ring system.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7601706 |
Bile-acid conjugates providing for sustained systemic concentration of drugs |
Oct. 13, 2009 |
| 7576055 |
Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
Aug. 18, 2009 |
| 7449572 |
Process and intermediates for preparing 17-halogenated 19-norsteroid compounds |
Nov. 11, 2008 |
| 7442790 |
Caspase inhibitors and uses thereof |
Oct. 28, 2008 |
| 7407947 |
Amphoteric sterols and the use thereof |
Aug. 5, 2008 |
| 7381718 |
Method for preparing oestrogen derivatives |
Jun. 3, 2008 |
| 7312206 |
Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances |
Dec. 25, 2007 |
| 6921757 |
Organic compounds |
Jul. 26, 2005 |
| 6780855 |
11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES AS WELL AS T |
Aug. 24, 2004 |
| 6670348 |
Methods and compositions for destruction of selected proteins |
Dec. 30, 2003 |
| 6583130 |
C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds |
Jun. 24, 2003 |
| 6566542 |
17-Halogenated 19-nor steroids, preparation process and intermediates, use as medicaments and the pharmaceutical compositions containing them |
May. 20, 2003 |
| 6541464 |
Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing them |
Apr. 1, 2003 |
| 6472382 |
4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them |
Oct. 29, 2002 |
| 6436917 |
Non-estrogenic estradiol derivative compounds with anti-oxidative activity |
Aug. 20, 2002 |
| 6423700 |
17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
Jul. 23, 2002 |
| 6399766 |
4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them |
Jun. 4, 2002 |
| 6355630 |
Estra-1,3,5(10)-triene-7.alpha.-thioethers |
Mar. 12, 2002 |
| 6339077 |
Substituted 4-benzylaminoquinolines and their hetero analogs, process for their preparation, pharmaceuticals containing these compounds and use thereof |
Jan. 15, 2002 |
| 6271403 |
7.alpha.-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(xi-aminoalkyl-estratrienes as well as their use for the produ |
Aug. 7, 2001 |
| 6258792 |
Cationic cholesteryl derivatives containing cyclic polar groups |
Jul. 10, 2001 |
| 6180618 |
Propanolamine derivatives linked to bile acids, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
Jan. 30, 2001 |
| 6080735 |
Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds |
Jun. 27, 2000 |
| 6046186 |
Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
Apr. 4, 2000 |
| 5866560 |
7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(.xi.-aminoalkyl)-estratrienes as well as their use for the |
Feb. 2, 1999 |
| 5824670 |
17-deoxycorticosteroid-21-[O]carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
Oct. 20, 1998 |
| 5760214 |
Bone resorption inhibition/osteogenesis promotion compound |
Jun. 2, 1998 |
| 5760025 |
Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses |
Jun. 2, 1998 |
| 5707982 |
19-nor-steroids |
Jan. 13, 1998 |
| 5705495 |
Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds |
Jan. 6, 1998 |
| 5668126 |
Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
Sep. 16, 1997 |
| 5646272 |
Bile acid conjugates of proline hydroxylase inhibitors |
Jul. 8, 1997 |
| 5646316 |
Bile acid inhibitors of metalloproteinase enzymes |
Jul. 8, 1997 |
| RE35517 |
Method, compositions, and compounds for modulating brain excitability |
May. 20, 1997 |
| 5608093 |
Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, and pharmaceuticals containing these compounds |
Mar. 4, 1997 |
| 5599806 |
Hydrazino and hydroxyamino-14-.beta.-hydroxyandrostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same |
Feb. 4, 1997 |
| 5583127 |
17-iminomethylalkenyl-5 .beta., 14 .beta.-androstane and 17-iminoalkyl-5 .beta., 14 .beta.-androstane derivatives active on the cardiovascular system, and pharmaceutical compositions containin |
Dec. 10, 1996 |
| 5556845 |
11-.beta. substituted-19-nor steroids |
Sep. 17, 1996 |
| 5462933 |
Modified bile acid conjugates, and their use as pharmaceuticals |
Oct. 31, 1995 |
| RE35053 |
Amines useful in producing pharmaceutically active CNS compounds |
Oct. 10, 1995 |
| 5424304 |
17-aryl-substituted steroidal compounds active on the cardiovascular system |
Jun. 13, 1995 |
| 5412091 |
16-methyl-.DELTA.1,4-pregnadiene-3,20-dione |
May. 2, 1995 |
| 5334713 |
N-long chain acyl neutral amino acid esters |
Aug. 2, 1994 |
| 5248773 |
16-methyl-.DELTA.1,4-pregnadiene-3,20-diones |
Sep. 28, 1993 |
| 5218109 |
Steroid compounds |
Jun. 8, 1993 |
| 5212166 |
Unsaturated 17.beta.-subsituted 3-carboxy steroids |
May. 18, 1993 |
| 5208227 |
Method, compositions, and compounds for modulating brain excitability |
May. 4, 1993 |
| 5149696 |
19.fwdarw.nor.fwdarw.steroids |
Sep. 22, 1992 |
| 5124321 |
17-halomethylene estratrienes |
Jun. 23, 1992 |
| 5120723 |
Method, compositions, and compounds for modulating brain excitability |
Jun. 9, 1992 |
|
|
|
